This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

El Djouhar Rekai, PhD
Head of Business Unit Peptide Process Development at PolyPeptide Group

Profile

Dr. Rekaï is Head of Process Development & Manufacturing Life Cycle Management, at PolyPeptide Group in Belgium, in charge of the R&D, scaling-up, validation and commercial process of the peptide projects. She obtained her PhD in Organic Chemistry (Sugar chemistry) from University of Pierre and Marie Curie in 1997. Then, she took up a post-doctoral position in Polymer chemistry at the University Catholique de Louvain in Belgium from 1998 to 1999. In January 2000, Dr. Rekaï started as peptide R&D Chemist at UCB-Bioproducts, Braine-l’Alleud (Belgium). Then, she specialized in chemical up scaling and validation before taking on the role of the overall Process Development and commercial stages in October 2013.

Agenda Sessions

  • Process Development and Control Strategy for an Efficient Large Scale Manufacturing Process

    11:15am